A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin Cancer Res. 2012 Jan 15; 18(2):577-84.